Drexel University College of Medicine

The purpose of these questions is to calculate a severity score of epistaxis (nose bleeding) for patients with Hereditary Hemorrhagic Telangiectasia. Treatment for epistaxis should be determined by a care provider with experience in treating patients with HHT, and this calculation should serve as an adjunct to clinical evaluation. For more information regarding the meaning of this score, please discuss this with you health care provider.

Please answer each of the following questions as they pertain to your TYPICAL symptoms WITHIN THE LAST 3 MONTHS for nose bleeding. Please answer all questions.

Please answer the following question(s):

1. How often do you TYPICALLY have nose bleeding?

Less than once per month Once per month Once per week Several per week Once per day Several per day

2. How long does your TYPICAL nose bleeding last?

< 1 minute 1-5 minutes 6-15 minutes 16-30 minutes > 30 minutes

3. How would you describe your TYPICAL nose bleeding intensity?

Not Typically Gushing or Pouring Typically Gushing or Pouring

4. Have you sought medical attention for your nose bleeding?

No Yes

5. Are you anemic (low blood counts) currently?

No Yes I don't know

6. Have you received a red blood cell transfusion SPECIFICALLY for nose bleeding?

No Yes

Helpful Guidelines and Recommendations:

Examples and Explanations
Research Recommendations
Other Considerations

Normalized Epistaxis Severity Score

Note: The HHT-ESS was developed by Jeffrey B. Hoag, M.D., M.S. from Drexel University College of Medicine in conjunction with Christian A. Merlo, M.D., M.P.H. and members of The Johns Hopkins University HHT Center of Excellence.

Funding for this project was generously provided by a grant from Cure HHT (previously The HHT Foundation International).